HCW Biologics Statistics Share Statistics HCW Biologics has 2.15M
shares outstanding. The number of shares has increased by 0.14%
in one year.
Shares Outstanding 2.15M Shares Change (YoY) 0.14% Shares Change (QoQ) 0.34% Owned by Institutions (%) 0.06% Shares Floating 1.63M Failed to Deliver (FTD) Shares 513 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 245.39K, so 11.4% of the outstanding
shares have been sold short.
Short Interest 245.39K Short % of Shares Out 11.4% Short % of Float 14.44% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -23.05 and the forward
PE ratio is -1.
HCW Biologics's PEG ratio is
-2.31.
PE Ratio -23.05 Forward PE -1 PS Ratio 269.62 Forward PS 9.8 PB Ratio -102.22 P/FCF Ratio -47.76 PEG Ratio -2.31
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for HCW Biologics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.19,
with a Debt / Equity ratio of -2.02.
Current Ratio 0.19 Quick Ratio 0.19 Debt / Equity -2.02 Debt / EBITDA -0.49 Debt / FCF -0.95 Interest Coverage -25.45
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $71.3K Profits Per Employee $-833.99K Employee Count 36 Asset Turnover 0.08 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -81.14% in the
last 52 weeks. The beta is 0.7, so HCW Biologics's
price volatility has been higher than the market average.
Beta 0.7 52-Week Price Change -81.14% 50-Day Moving Average 4.4 200-Day Moving Average 9.35 Relative Strength Index (RSI) 46.77 Average Volume (20 Days) 1,958,495
Income Statement In the last 12 months, HCW Biologics had revenue of 2.57M
and earned -30.02M
in profits. Earnings per share was -0.77.
Revenue 2.57M Gross Profit 959.4K Operating Income -29.48M Net Income -30.02M EBITDA -27.68M EBIT -28.87M Earnings Per Share (EPS) -0.77
Full Income Statement Balance Sheet The company has 4.67M in cash and 13.69M in
debt, giving a net cash position of -9.02M.
Cash & Cash Equivalents 4.67M Total Debt 13.69M Net Cash -9.02M Retained Earnings -100.56M Total Assets 28.91M Working Capital -23.95M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.23M
and capital expenditures -261.62K, giving a free cash flow of -14.49M.
Operating Cash Flow -14.23M Capital Expenditures -261.62K Free Cash Flow -14.49M FCF Per Share -0.37
Full Cash Flow Statement Margins Gross margin is 37.38%, with operating and profit margins of -1148.5% and -1169.7%.
Gross Margin 37.38% Operating Margin -1148.5% Pretax Margin -1169.7% Profit Margin -1169.7% EBITDA Margin -1078.43% EBIT Margin -1148.5% FCF Margin -564.48%
Dividends & Yields HCWB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for HCWB is $35,
which is 757.8% higher than the current price. The consensus rating is "Buy".
Price Target $35 Price Target Difference 757.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 11, 2025. It was a
backward
split with a ratio of 1:40.
Last Split Date Apr 11, 2025 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -7.32 Piotroski F-Score 4
